View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, Jan. 11 (HealthDay News) -- Patients with very mild Alzheimer's disease show improvements in memory after taking a multi-nutrient drink designed to improve synapse formation, according to a study in the January issue of Alzheimer's & Dementia.
Philip Scheltens, M.D., of VU University Medical Center in Amsterdam, Netherlands, and colleagues randomly assigned 225 patients with mild Alzheimer's disease to Souvenaid, a multi-nutrient drink, or a control drink once a day for 12 weeks.
The researchers found that Souvenaid was well tolerated and that patients taking Souvenaid had significant improvement in the delayed verbal recall task. However, no changes were observed in several other scores examining outcomes such as quality of life. Patients taking the control drink showed no changes.
"Supplementation with a medical food including phosphatide precursors and cofactors for 12 weeks improved memory (delayed verbal recall) in mild Alzheimer's disease patients," the authors conclude.
One author is an employee of Danone Research, and several others reported advisory or consulting relationships with Danone and Nutricia. Another author works at an academic medical center that receives unrestricted funding from Danone Research.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top